Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-08 4:30 pm Purchase |
2025-04-01 | 13G | Regulus Therapeutics Inc. RGLS |
Point72 Asset Management, L.P. | 3,923,806 5.900% |
3,923,806 (New Position) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
RA Capital Management, L.P. | 766,834 1.200% |
766,834 (New Position) |
Filing History |
| 2024-11-14 4:32 pm Purchase |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
BIOTECHNOLOGY VALUE FUND L P | 883,844 1.300% |
883,844 (New Position) |
Filing History |
| 2024-11-14 2:35 pm Sale |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
DAFNA Capital Management LLC | 895,200 1.370% |
-215,849 (-19.43%) |
Filing History |
| 2024-11-12 4:45 pm Unchanged |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
The Vanguard Group | 4,088,760 6.240% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
BLACKROCK INC BLK |
4,081,038 6.200% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:46 pm Purchase |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
The Vanguard Group | 4,088,760 6.240% |
4,088,760 (New Position) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
BLACKROCK INC BLK |
4,081,038 6.200% |
4,081,038 (New Position) |
Filing History |
| 2024-10-11 4:02 pm Purchase |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
Octagon Capital Advisors LP | 4,263,701 6.500% |
4,263,701 (New Position) |
Filing History |
| 2024-04-10 10:06 am Unchanged |
2024-04-09 | 13G | Regulus Therapeutics Inc. RGLS |
FMR CORP | 2,922,600 4.464% |
0 (Unchanged) |
Filing History |
| 2024-03-25 4:18 pm Purchase |
2024-03-14 | 13G | Regulus Therapeutics Inc. RGLS |
RA Capital Management, L.P. | 6,250,000 9.500% |
6,250,000 (New Position) |
Filing History |
| 2024-03-22 4:03 pm Purchase |
2024-03-12 | 13G | Regulus Therapeutics Inc. RGLS |
Deep Track Capital, LP | 6,888,424 9.990% |
6,888,424 (New Position) |
Filing History |
| 2024-03-20 4:30 pm Purchase |
2024-03-14 | 13G | Regulus Therapeutics Inc. RGLS |
Vivo Opportunity Fund Holdings, L.P. | 5,000,000 7.700% |
5,000,000 (New Position) |
Filing History |
| 2024-03-18 9:13 pm Purchase |
2024-03-14 | 13D | Regulus Therapeutics Inc. RGLS |
Growth Equity Opportunities V LLC | 6,533,102 9.990% |
4,587,523 (+235.79%) |
Filing History |
| 2024-02-14 2:54 pm Purchase |
2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
DAFNA Capital Management LLC | 1,111,049 5.490% |
1,111,049 (New Position) |
Filing History |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Regulus Therapeutics Inc. RGLS |
FMR CORP | 2,922,600 14.452% |
727,600 (+33.15%) |
Filing History |
| 2024-02-06 11:06 am Purchase |
2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
Victory Capital Management, Inc. | 1,155,516 5.710% |
305,319 (+35.91%) |
Filing History |
| 2024-01-18 10:25 am Purchase |
2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
FEDERATED HERMES INC. FHI |
4,023,860 19.900% |
148,282 (+3.83%) |
Filing History |
| 2023-05-12 1:57 pm Purchase |
2023-04-13 | 13D | Regulus Therapeutics Inc. RGLS |
Growth Equity Opportunities V LLC | 1,945,579 9.990% |
487,327 (+33.42%) |
Filing History |
| 2023-05-10 09:58 am Purchase |
2023-04-30 | 13G | Regulus Therapeutics Inc. RGLS |
FEDERATED HERMES INC. FHI |
3,875,578 19.900% |
970,752 (+33.42%) |
Filing History |